Summary
No overall score for this company yet.
What speaks for it
- It has been profitable 6 years in a row.
What to watch
- Revenue fell by 8.6% a year over the last 3 years.
- It passes only 1 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 5 times in the last 7 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Is it growing?
Revenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 7.0% a year over 5 years. Over the last 3 years it fell by 8.6% a year. Earnings per share fell by 10% a year over the last 3 years.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $30.7M.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 3
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.